More information: Martin Wermke et al, Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a ...

University of Galway’s Dr Ruth Levey is advancing the field of cell therapy delivery to treat chronic diseases.

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

The Polytechnic University (PolyU) says it is tapping into the world of precision medicine as it develops long-term treatment ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

An international research group led by scientists has now succeeded in a phase 1 clinical trial in testing a novel cell therapy approach that also shows promise for solid tumors. In recent years ...

Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors One ...